Memantine in Patients With Chronic Glaucoma

Randomized double-masked clinical trial of memantine in patients with glaucoma

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Open-angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Glaucoma damage on examination of visual field and optic disc
Good visual acuity (with glasses if needed)

Treatment and study plan

Memantine

Drug

Primary outcomes

Progression of glaucoma

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 1999
Primary completion: 2006
Study completion: 2006
First posted: Sep 2, 2005
Registry last updated: Nov 4, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed